Results 221 to 230 of about 1,596,449 (302)

Cost-consequence analysis of early vs. delayed natalizumab use in highly active relapsing-remitting multiple sclerosis: a simulation study. [PDF]

J Neurol
Inojosa H, Schriefer D, Ness NH, Dillenseger A, Akgün K, Ziemssen T.   +5 more
europepmc   +1 more source

The Fatal Flaw of Cost-Benefit Analysis: The Problem of Person-Altering Consequences

, 2008
Gregory S. Crespi
openalex   +1 more source

Impact Of Yag Laser Capsulotomy Procedures On Cataract Center Chair Time And Revenue Opportunity- A Cost Consequence Analysis At A Private Facility In India

Jun Zhang, Rajeev Nandan, Prashanth Prabhuswamy, Rachapalle Reddi Sudhir   +3 more
openalex   +1 more source

EE778 Early Cost-Consequence Analysis of Comprehensive Genomic Profiling in a Metastasized Tumor-Agnostic Population [PDF]

Leon van Schaik, Brigitte Maes, Pieter‐Jan Volders, Guy Froyen, Hedwig M. Blommestein, Wim H. van Harten, Valesca P. Retèl   +6 more
openalex   +1 more source

Building a Framework for Sexual and Reproductive Health Care in the Rheumatology Context: Content and Approaches

Arthritis Care &Research, EarlyView.
People with systemic autoimmune and rheumatic diseases (SARDs) are at higher risk than the general population of experiencing adverse pregnancy and perinatal outcomes such as preeclampsia, intrauterine growth restriction, and maternal and/or fetal death.
Mehret Birru Talabi, Sonya Borrero
wiley   +1 more source

A Cost-Consequence Analysis of Nutritional Interventions Used in Hospital Settings for Older Adults with or at Risk of Malnutrition. [PDF]

Healthcare (Basel)
Wong A, Huang Y, Banks MD, Sowa PM, Bauer JD.   +4 more
europepmc   +1 more source

Consequences of ceilings on the use of Kyoto mechanisms: a tentative analysis of cost effects for EU Member States [PDF]

, 1999
J.R. Ybema, T. Kram, S.N.M. van Rooijen
openalex  

Real‐World Longitudinal Data on the Impact of Hydroxychloroquine Blood Level Monitoring on Lupus Outcomes: Results of a Prospective Longitudinal Cohort Study

Arthritis Care &Research, EarlyView.
Objective Hydroxychloroquine (HCQ) is a cornerstone therapy in systemic lupus erythematosus (SLE), but the weight‐based dosing does not account for clinical factors that can introduce individual variability in drug metabolism and clearance. We leveraged longitudinal data from a prospective SLE cohort to identify clinical factors that predict ...
Jay J. Patel, Fauzia Hollangel, Caroline Packee, Amita Kapoor, Brad Rovin, Nathalie Costedoat‐Chalumeau, Shivani Garg   +6 more
wiley   +1 more source

The Association of Physical Function With Psychosocial Patient‐Reported Outcomes in People With Systemic Lupus Erythematosus

Arthritis Care &Research, EarlyView.
Objective To evaluate how modifiable psychosocial factors and fatigue relate to physical functioning in patients with systemic lupus erythematosus (SLE). Methods In this cross‐sectional study of two demographically distinct cohorts (Approaches to Positive, Patient‐Centered Experiences of Aging with Lupus [APPEAL] and California Lupus Epidemiology Study
Mrinalini Dey, Jessica Fitzpatrick, Maria Dall'Era, Charmayne Dunlop‐Thomas, Courtney Hoge, S. Sam Lim, Patricia P. Katz, Jinoos Yazdany, Laura C. Plantinga   +8 more
wiley   +1 more source

Treatment discontinuation in adults with atypical hemolytic uremic syndrome (aHUS): a qualitative study of international experts' perspectives with associated cost-consequence analysis. [PDF]

BMC Nephrol
Germeni E, Cooper J, Briggs A, Laurence J.   +3 more
europepmc   +1 more source